Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 21 studies | 24% ± 12% | |
pericyte | 9 studies | 20% ± 6% | |
oligodendrocyte | 8 studies | 25% ± 7% | |
endothelial cell | 7 studies | 22% ± 4% | |
smooth muscle cell | 7 studies | 19% ± 2% | |
adipocyte | 7 studies | 27% ± 11% | |
glutamatergic neuron | 6 studies | 42% ± 24% | |
GABAergic neuron | 6 studies | 34% ± 17% | |
interneuron | 5 studies | 36% ± 22% | |
epithelial cell | 4 studies | 34% ± 4% | |
astrocyte | 4 studies | 26% ± 6% | |
oligodendrocyte precursor cell | 4 studies | 27% ± 8% | |
connective tissue cell | 4 studies | 22% ± 6% | |
plasmacytoid dendritic cell | 4 studies | 21% ± 8% | |
ciliated cell | 3 studies | 25% ± 4% | |
myofibroblast cell | 3 studies | 24% ± 2% | |
macrophage | 3 studies | 19% ± 2% | |
basal cell | 3 studies | 27% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2352.75 | 459 / 459 | 100% | 5.64 | 1118 / 1118 |
prostate | 100% | 1857.38 | 245 / 245 | 100% | 4.54 | 502 / 502 |
esophagus | 100% | 1872.52 | 1444 / 1445 | 100% | 3.33 | 183 / 183 |
brain | 100% | 1843.47 | 2636 / 2642 | 100% | 5.46 | 705 / 705 |
thymus | 100% | 1788.09 | 653 / 653 | 100% | 4.50 | 603 / 605 |
pancreas | 100% | 1833.05 | 328 / 328 | 99% | 4.08 | 177 / 178 |
lung | 99% | 1464.29 | 575 / 578 | 100% | 3.54 | 1154 / 1155 |
uterus | 100% | 3042.35 | 170 / 170 | 99% | 4.05 | 456 / 459 |
ovary | 100% | 2831.77 | 180 / 180 | 99% | 3.27 | 426 / 430 |
bladder | 100% | 2522.62 | 21 / 21 | 98% | 3.27 | 495 / 504 |
kidney | 100% | 1116.04 | 89 / 89 | 98% | 3.56 | 879 / 901 |
intestine | 100% | 1942.01 | 966 / 966 | 97% | 3.57 | 511 / 527 |
stomach | 100% | 1517.64 | 359 / 359 | 97% | 3.48 | 277 / 286 |
adrenal gland | 100% | 1399.35 | 258 / 258 | 97% | 3.67 | 222 / 230 |
skin | 100% | 2274.04 | 1808 / 1809 | 90% | 3.48 | 427 / 472 |
liver | 94% | 585.39 | 213 / 226 | 92% | 1.94 | 374 / 406 |
adipose | 100% | 2442.01 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 2.27 | 29 / 29 |
spleen | 100% | 1034.76 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 2.76 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.63 | 1 / 1 |
blood vessel | 100% | 1813.40 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 848.52 | 788 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 1051.71 | 823 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 55% | 1.28 | 44 / 80 |
peripheral blood | 27% | 261.36 | 248 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006400 | Biological process | tRNA modification |
GO_0005634 | Cellular component | nucleus |
GO_0016432 | Molecular function | tRNA-uridine aminocarboxypropyltransferase activity |
Gene name | DTWD1 |
Protein name | DTW domain containing 1 tRNA-uridine aminocarboxypropyltransferase 1 (EC 2.5.1.25) (DTW domain-containing protein 1) |
Synonyms | MDS009 |
Description | FUNCTION: Catalyzes the formation of 3-(3-amino-3-carboxypropyl)uridine (acp3U) at position 20 in the D-loop of several cytoplasmic tRNAs (acp3U(20)). . FUNCTION: Catalyzes the formation of 3-(3-amino-3-carboxypropyl)uridine (acp3U) at position 20 in the D-loop of several cytoplasmic tRNAs (acp3U(20)). . FUNCTION: Catalyzes the formation of 3-(3-amino-3-carboxypropyl)uridine (acp3U) at position 20 in the D-loop of several cytoplasmic tRNAs (acp3U(20)). . |
Accessions | Q8N5C7 ENST00000559164.5 H0YL61 ENST00000557968.5 [Q8N5C7-3] H0YML0 ENST00000560632.5 ENST00000557988.5 ENST00000558653.5 [Q8N5C7-1] H0YK73 ENST00000559405.5 ENST00000251250.7 [Q8N5C7-1] ENST00000403028.8 [Q8N5C7-1] H0YMP4 |